Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. (SHE:301617)
53.00
+1.00 (1.92%)
At close: Jun 2, 2026
SHE:301617 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 517.62 | 346.27 | 958.58 | 228.52 | 80 | 46.5 |
Trading Asset Securities | 95 | 310 | - | - | 69.15 | 23.52 |
Cash & Short-Term Investments | 612.62 | 656.27 | 958.58 | 228.52 | 149.15 | 70.02 |
Cash Growth | -28.05% | -31.54% | 319.47% | 53.22% | 112.99% | 181.71% |
Accounts Receivable | 204.42 | 208.81 | 182.43 | 169.27 | 121.25 | 105.25 |
Other Receivables | 1.64 | 1.68 | 1.63 | 4.7 | 0.74 | 2.43 |
Receivables | 206.07 | 210.49 | 184.06 | 173.97 | 121.99 | 107.67 |
Inventory | 334.09 | 321.88 | 210.39 | 171.37 | 137.1 | 104.03 |
Prepaid Expenses | - | - | - | - | 0.47 | - |
Other Current Assets | 190.46 | 148.28 | 25.67 | 21.02 | 11.72 | 28.17 |
Total Current Assets | 1,343 | 1,337 | 1,379 | 594.88 | 420.43 | 309.89 |
Property, Plant & Equipment | 526.82 | 523.44 | 440.93 | 369.2 | 331.44 | 187.82 |
Other Intangible Assets | 59.97 | 60.5 | 62.28 | 56.54 | 58.32 | 58.01 |
Long-Term Deferred Tax Assets | 1.09 | 1.11 | 0.69 | 0.67 | 0.36 | 0.72 |
Long-Term Deferred Charges | 0.93 | 0.98 | - | - | - | - |
Other Long-Term Assets | 19.33 | 6.16 | 1.22 | 1.72 | 1.1 | 2.58 |
Total Assets | 1,971 | 1,929 | 1,884 | 1,023 | 811.65 | 559.02 |
Accounts Payable | 115.48 | 128.74 | 161.85 | 143.08 | 134.32 | 51.92 |
Accrued Expenses | 8.15 | 16.35 | 21.13 | 14.94 | 15.7 | 13.42 |
Short-Term Debt | - | 0.56 | - | - | 1 | 0.38 |
Current Portion of Leases | 0.24 | 0.24 | 0.27 | 0.26 | 0.97 | 1.1 |
Current Income Taxes Payable | 16.88 | 5.31 | 7.03 | 4.71 | 2.33 | 4.39 |
Current Unearned Revenue | 2.79 | 3.08 | 4.01 | 4.39 | 2.86 | 4.4 |
Other Current Liabilities | 46.4 | 45.06 | 32.88 | 46.78 | 26.36 | 31.72 |
Total Current Liabilities | 189.94 | 199.34 | 227.17 | 214.16 | 183.56 | 107.33 |
Long-Term Leases | 0.98 | 1.04 | - | 0.27 | 0.6 | 1.43 |
Total Liabilities | 190.92 | 200.38 | 227.17 | 214.43 | 184.16 | 108.76 |
Common Stock | 133.64 | 133.64 | 102.8 | 77.1 | 77.1 | 77.1 |
Additional Paid-In Capital | 808.25 | 808.02 | 850.45 | 239.32 | 238.83 | 238.25 |
Retained Earnings | 837.91 | 786.87 | 702.98 | 491.13 | 309.02 | 132.7 |
Comprehensive Income & Other | 0.65 | 0.2 | 0.42 | 1.03 | 2.54 | 2.21 |
Shareholders' Equity | 1,780 | 1,729 | 1,657 | 808.58 | 627.49 | 450.26 |
Total Liabilities & Equity | 1,971 | 1,929 | 1,884 | 1,023 | 811.65 | 559.02 |
Total Debt | 1.21 | 1.83 | 0.27 | 0.53 | 2.58 | 2.9 |
Net Cash (Debt) | 611.4 | 654.43 | 958.31 | 227.99 | 146.57 | 67.12 |
Net Cash Growth | -28.17% | -31.71% | 320.32% | 55.55% | 118.37% | - |
Net Cash Per Share | 3.52 | 3.77 | 9.56 | 1.75 | 1.12 | 0.54 |
Filing Date Shares Outstanding | 173.73 | 173.73 | 173.73 | 130.3 | 130.3 | 130.3 |
Total Common Shares Outstanding | 173.73 | 173.73 | 173.73 | 130.3 | 130.3 | 130.3 |
Working Capital | 1,153 | 1,138 | 1,152 | 380.72 | 236.87 | 202.56 |
Book Value Per Share | 10.25 | 9.95 | 9.54 | 6.21 | 4.82 | 3.46 |
Tangible Book Value | 1,720 | 1,668 | 1,594 | 752.05 | 569.17 | 392.25 |
Tangible Book Value Per Share | 9.90 | 9.60 | 9.18 | 5.77 | 4.37 | 3.01 |
Buildings | - | 200.71 | 142.47 | 135.44 | 56.68 | 56.19 |
Machinery | - | 370.75 | 197.12 | 171.13 | 153.79 | 147.45 |
Construction In Progress | - | 95.58 | 216.59 | 149.81 | 187.42 | 35.07 |